| 000 | 01235 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516041932.0 | ||
| 264 | 0 | _c20111207 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1873-5576 | ||
| 024 | 7 |
_a10.2174/156800911796191006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoehler, M | |
| 245 | 0 | 0 |
_aEsophagogastric cancer: integration of targeted therapies into systemic chemotherapy. _h[electronic resource] |
| 260 |
_bCurrent cancer drug targets _cJul 2011 |
||
| 300 |
_a681-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
| 700 | 1 | _aSchwarz, S | |
| 700 | 1 | _aWagner, A D | |
| 773 | 0 |
_tCurrent cancer drug targets _gvol. 11 _gno. 6 _gp. 681-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/156800911796191006 _zAvailable from publisher's website |
| 999 |
_c20908586 _d20908586 |
||